| |
|
|
The Inflammatory Bowel Disease Newsletter, 2002 Crohn's and Colitis Research Centre, Royal Brisbane Hospital.
Clinical Trials in IBD
We are always searching for safe and effective new treatments for our patients. The role of clinical trials is to assess these new drugs in a safe and controlled way.
We have been involved in 4 major clinical trials over the past 3 years, of which 3 have involved patients with CD. Many of our patients have benefited directly from these new agents, and some of these medications will eventually be available to a wider IBD population.
Although the anti-TNF drug called infliximab (remicade) has not been involved in clinical trials for CD in Australia, we have led the way in helping to determine which patients may benefit most from this drug and how its beneficial effects can be maximized.
There will be further trials using drugs such as infliximab for both UC and CD in the new year.
|
 |